{
  "ptid_time": "116_S_4167_2011-08-10",
  "img_path": "/data/qiuhui/data/adni/images/116_S_4167/2011-08-10/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 38,088 mm³, 70.5% above the reference mean. With a Z-score of 1.76 (96.1th percentile), this represents moderate enlargement; hippocampal volume measures 5,771 mm³, 24.9% below the reference mean. With a Z-score of -2.79 (0.3th percentile), this represents significant atrophy; whole brain volume measures 1,000,110 mm³, 2.8% below the reference mean. With a Z-score of -0.35 (36.3th percentile), this represents normal volume ; entorhinal cortex volume measures 2,934 mm³, 24.6% below the reference mean. With a Z-score of -1.91 (2.8th percentile), this represents moderate atrophy; fusiform gyrus volume measures 18,620 mm³, 2.3% above the reference mean. With a Z-score of 0.25 (60.0th percentile), this represents normal volume ; middle temporal gyrus volume measures 19,634 mm³, 4.3% below the reference mean. With a Z-score of -0.38 (35.1th percentile), this represents normal volume . ",
  "text_data": "Age is 69.5 years. Gender is Female. Education: 16 years. Handedness: Right. Race: White. Medical history: Psychiatric; Head, Eyes, Ears, Nose and Throat; Hepatic; Musculoskeletal; Endocrine-Metabolic; Gastrointestinal; Renal-Genitourinary; Allergies or Drug Sensitivities; Major Surgical Procedures. MMSE: 28.0. MoCA: 16.0. Logical Memory: 1.0. Laboratory findings: Eosinophils: 0.36 (significant elevated). APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.58 SUVR (profound elevated); Amyloid beta: 645.30 pg/mL (normal ); Total tau: 301.70 pg/mL (normal ); Phosphorylated tau: 29.43 pg/mL (mild elevated). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The imaging shows significant hippocampal atrophy (Z-score -2.79) and moderate entorhinal cortex atrophy (Z-score -1.91), both key regions in Alzheimer's pathology. The MMSE is normal (28/30), but the MoCA (16/30) suggests cognitive impairment, alongside elevated AV45 (amyloid PET) and mildly elevated P-tau, indicating amyloid pathology and neurodegeneration.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI) due to Alzheimer’s disease**  \n**Confidence:** **High**  \n\n*(The discrepancy between MMSE and MoCA suggests early cognitive deficits, while imaging and biomarkers strongly support Alzheimer’s pathology. Aβ is normal, but AV45 is elevated, which may reflect early amyloid accumulation before CSF changes.)*",
  "timestamp": "2025-07-26T12:07:50.080964"
}